Prioritization of intellectual capital indicators in knowledge-based industries: Evidence from pharmaceutical industry

Mehralian, Gholamhossein; Rasekh, Hamid Reza; Akhavan, Peyman; Ghatari, Ali Rajabzadeh

doi:10.1016/j.ijinfomgt.2012.10.002

Cited by 77 publications

(53 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Trade mark must be registered, and the generic name must be published on the labeling along with the brand name. IPR is a controversial issue in pharm-emerging markets [40]. Iran's membership to World Trade Organization will have a drastic impact on the pharmaceutical market because the copy of patented medicines in the market will be restricted and it needs further resource allocation for novel and hi-tech medicines.…”

Section: Discussionmentioning

confidence: 99%

A Framework for Evaluation of Pharmaceutical Industry Development in Developing Countries: Evidence From Iran

Shabaninejad¹,

Madani²,

Amineh³

et al. 2016

Asian J Pharm Clin Res

View full text Add to dashboard Cite

Objectives:The pharmaceutical market is a complex market due to its complicated supply chain and the extent of government regulations in all aspects of the trade lifecycle of drug development. Considering the importance of pharmaceuticals for society and the relevant trend of globalization, managing pharmaceutical industry effectively and efficiently is vital, particularly in developing countries. The present study determines the factors affecting the development of the Iranian pharmaceutical industry based on pharmaceutical mangers' point of view. Methods:In this study, we assessed managers' perspective about the internal and external key factors affecting the development of pharmaceutical industry. Finally, their perspective about the solutions for the development of pharmaceutical industry was assessed. Accordingly, a self-designed questionnaire was sent to 65 managers at Tamin Pharmaceutical Investment Company, of which, 51 questionnaires were answered by the managers.Result: Most managers believed generic scheme reflect negatively on the development of the pharmaceutical industry and that external factors have a great impact on its improvement. They believe that branded generic transition along with supporting regulations, investment in Research and Development, and joint venture with foreign companies will improve the pharmaceutical industry. Conclusion:To sum up, for improving the pharmaceutical industry in the shortest time possible, improvement of technological capabilities and investment in R&D should be considered.

show abstract

Section: Discussionmentioning

confidence: 99%

A Framework for Evaluation of Pharmaceutical Industry Development in Developing Countries: Evidence From Iran

Shabaninejad¹,

Madani²,

Amineh³

et al. 2016

Asian J Pharm Clin Res

View full text Add to dashboard Cite

show abstract

“…Health complains (HCavg) -total number of complaints (related to health) per product (Mehralian et al, 2013):…”

Section: Consumer Health and Safetymentioning

confidence: 99%

“…Average period of relationship (REL) -average duration of contracts that company has with their clients (Mehralian et al, 2013):…”

Section: Product Management and Consumer Satisfactionmentioning

confidence: 99%

Quantitative indicators for social sustainability assessment of society and product responsibility aspects in supply chains

Popović

Krasławski

Barbosa‐Póvoa

et al. 2017

Journal of International Studies

View full text Add to dashboard Cite

Abstract. Increased pressures from stakeholders have been forcing companies to integrate social sustainability into their businesses. However, lack of information leads to gaps in social sustainability, some of them being also related to difficulties in social sustainability assessment of supply chains often caused by lack of appropriate quantitative indicators to be used. Vol.10, No.4, 2017 10 responsibility issues. The indicators are validated through content analysis of 141 sustainability reports from all echelons (upstream, midstream, downstream) of a supply chain. Beyond that, one-way statistical analysis (ANOVA) is performed in order to analyse how echelon levels affect the relevance of these indicators. Content analysis results confirm that issues covered by the indicators are addressed by the companies in their sustainability reports, while ANOVA analysis shows that supply chain echelon level does not influence the relevance of the indicators, making this set of indicators generic and applicable to any supply chain. Therefore, these indicators can be considered as generic and used for the holistic assessment of supply chains.

show abstract

“…In the context of knowledge-based organizations, such as judiciary organizations, Mehralian, Reza, Akhavan, and Rajabzadeh (2013) argue that human capital has become a critical factor for longterm productivity and performance. Based on this finding, the present study differentiated own and outsourced human capital, the latter related to contracts with a limited period, which normally do not exceed four years.…”

Section: Causal Relationship Between Amount Of Human Capital and Prodmentioning

confidence: 99%

Productivity Antecedents of Brazilian Courts of Justice: Evidence from Justiça em Números

Louro

Santos

Filho

2017

BAR, Braz. Adm. Rev.

View full text Add to dashboard Cite

Public sector managers and researchers have emphasized the importance of performance measurement. Nevertheless, few theoretical and empirical studies are found in Brazilian Judiciary Courts' literature. In order to empirically identify which variables (IT investments, own or outsourced human capital) are more relevant for improving productivity, the current research proposes a model using secondary data extracted from the Justiça em Números (Justice in Numbers) report, using structural equation modeling for the analysis. The results suggest that: (a) all variables are relevant for improving productivity in Brazilian Courts, confirming our first three theoretical hypotheses; and (b) own human capital has a greater impact on productivity than outsourced, confirming the fourth. For those who are responsible for reforms, this finding indicates that IT is not the most important investment. However a question remains: Seen as a cure for almost all problems in the public sector, is it possible to improve performance without hard IT investments? For future research there are some additional questions: Why is own human capital more relevant than outsourced? Which variables should be included in the model for improving the general significance? The answers can help improve Brazilian court productivity.

show abstract

Prioritization of intellectual capital indicators in knowledge-based industries: Evidence from pharmaceutical industry

Cited by 77 publications

References 41 publications

A Framework for Evaluation of Pharmaceutical Industry Development in Developing Countries: Evidence From Iran

A Framework for Evaluation of Pharmaceutical Industry Development in Developing Countries: Evidence From Iran

Quantitative indicators for social sustainability assessment of society and product responsibility aspects in supply chains

Productivity Antecedents of Brazilian Courts of Justice: Evidence from Justiça em Números

Contact Info

Product

Resources

About